Medical Saints Targets Christina Lake Cannabis in $18M Deal

VANCOUVER, BC – Christina Lake Cannabis Corp. (CLC) has received an unsolicited $18 million cash purchase offer for substantially all of its assets from Ontario licensed producer Medical Saints Ltd. setting up a competing transaction scenario for the company’s board of directors.

The proposed asset sale represents a structural departure from an earlier non-binding letter of intent (LOI) disclosed on August 21, 2026, in which an unnamed private Alberta corporation offered $15 million to acquire 100% of CLC’s issued and outstanding shares.

Under terms signed on September 11, 2026, the Medical Saints proposal provides an $18 million cash consideration on a cash-free, debt-free basis. The agreement includes a $2 million advance payment delivered upon execution of a definitive agreement, which serves as liquidated damages should the buyer fail to close due to breach or funding default. The terms establish a 40-day exclusivity period for due diligence and definitive agreement negotiations, subject to board fiduciary obligations.

Unlike the initial share-swap LOI, which required debt payoffs from net proceeds, the Medical Saints offer explicitly targets physical and operating assets. The scope includes CLC’s 32-acre primary cultivation site, 342-acre secondary property, processing infrastructure, inventory, patents, trademarks, and customer contracts.

Medical Saints operates three facilities across Ontario, producing approximately 100 tons of Cannabis annually. CEO Lucas Leone cited CLC’s high-volume extraction capabilities and large-scale outdoor canopy as primary drivers for the acquisition bid.

A Special Committee of CLC’s Board of Directors is evaluating both proposals concurrently. Neither proposal has resulted in a binding definitive agreement, and any asset sale to Medical Saints remains subject to shareholder, judicial, and regulatory approvals.

The competing proposals for Christina Lake Cannabis underscore a pivot in how M&A transactions are structured within the Canadian market. The contrast between a $15 million equity buyout and an $18 million cash asset purchase reflects buyer preference for isolating physical infrastructure from legacy corporate liabilities. In a market marked by biomass price compression and historical inventory write-downs, asset-level deals allow acquiring operators to cherry-pick operational real estate and extraction hardware without inheriting balance sheet drag.

For Medical Saints, targeting CLC’s outdoor cultivation footprint and processing capacity represents a clear scale play. Securing lower-cost input material and extraction facilities in British Columbia allows the Ontario operator to optimize downstream unit economics across its national distribution channels. The inclusion of a $2 million cash deposit further highlights the aggressive stance private buyers are willing to take to lock up high-throughput assets.